BAXTER INTERNATIONAL INC (BAX) — SEC Financial Statements & Analysis

BAXTER INTERNATIONAL INC (BAX) is a surgical & medical instruments & apparatus company, incorporated in DE. BAXTER INTERNATIONAL INC trades on NYSE as: BAX. BAXTER INTERNATIONAL INC (BAX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30. Based on that filing, BAXTER INTERNATIONAL INC carries a market cap of $11.02B, a P/E ratio of -10.37x, a P/B ratio of 1.78x, a P/S ratio of 0.96x, an enterprise value of $9.71B, and an EV/EBITDA multiple of 14.30x. On profitability, it posts a gross margin of 30.08%, an operating margin of -2.39%, a net margin of -9.27%, a Return on Equity (ROE) of -15.78%, a Return on Assets (ROA) of -5.21%, and a Return on Invested Capital (ROIC) of -5.01%. Per share, it reports EPS of $-2.06, diluted EPS of $-2.05, free cash flow per share of $2.55, and a dividend per share of $0.36. Over the trailing year, it posted revenue growth of 5.36% year-over-year, net income growth of 623.13% year-over-year, and EPS growth of 617.53% year-over-year. On the balance sheet, it maintains a current ratio of 1.95x, a quick ratio of 1.12x, working capital of $3.40B, a debt-to-equity ratio of 2.20x, a debt ratio of 0.69, an interest coverage ratio of -1.11x, free cash flow of $1.32B (TTM), and net debt of $-1.31B. Figures sourced from SEC EDGAR.

Market Cap

$11.02B

P/E TTM

-10.37x

EPS TTM

$-2.06

P/B TTM

1.78x

ROE TTM

-15.78%

ROA TTM

-5.21%

Debt To Equity

2.20x

Free Cash Flow TTM

$1.32B

Net Revenue TTM Growth 1Y

5.36%

Data as of 2026-06-30 · Source: SEC EDGAR